HEIDI KENG: Open Payments
NPI 1962835991 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 17 payments from 8 companies in 2025. Trend: 2023 $592 · 2024 $618 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $192 |
| United Therapeutics Corporation | 3 | $76 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $45 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| PFIZER INC. | 1 | $18 |
Products named: CARDIOMEMS, Tyvaso, LifeVest, WINREVAIR, AMVUTTRA, JARDIANCE, ORENITRAM, Kerendia.
Industry payments across CA — which companies pay providers there.
